MARKET

GSK

GSK

GSK PLC
NYSE
50.45
+0.15
+0.30%
Pre Market: 49.04 -0.96 -1.92% 04:31 08/14 EDT
OPEN
50.56
PREV CLOSE
50.30
HIGH
50.63
LOW
50.18
VOLUME
7.07K
TURNOVER
--
52 WEEK HIGH
60.66
52 WEEK LOW
36.34
MARKET CAP
102.05B
P/E (TTM)
16.12
1D
5D
1M
3M
1Y
5Y
1D
Splitting the MMR vaccine? Experts warn it could take a decade
Seeking Alpha · 1d ago
U.K. regulator reaffirms safety of childhood vaccination
Seeking Alpha · 1d ago
Barclays Sticks to Its Sell Rating for GlaxoSmithKline (GSK)
TipRanks · 2d ago
Trump Trade: President signs EO to split up of childhood vaccines
TipRanks · 2d ago
Jefferies Sticks to Their Buy Rating for GlaxoSmithKline (GSK)
TipRanks · 2d ago
Trump signs EO to split up of childhood vaccines, Bloomberg reports
TipRanks · 3d ago
Trump executive order set to make major changes to childhood vaccines schedule
Seeking Alpha · 3d ago
Gilead Sciences: The Market May Be Underestimating Its Growth (Rating Upgrade)
Seeking Alpha · 3d ago
More
About GSK
GSK plc is a United Kingdom-based biopharma company. The Company is focused on the science of the immune system and advanced technologies, investing in four core therapeutic areas-respiratory, immunology and inflammation; oncology; human immunodeficiency virus (HIV), and infectious diseases. Its segments include Commercial Operations and Research and Development. Its specialty medicines prevent and treat diseases, from asthma, cancer and HIV to autoimmune diseases like lupus. General medicines include inhalers for asthma and chronic obstructive pulmonary disease (COPD) to antibiotics. It also owns ozureprubart, a long-acting anti-immunoglobulin E (IgE) monoclonal antibody and HS235, a potential molecule for the treatment of pulmonary hypertension (PH). Its oncology portfolio also includes Zidesamtinib (NVL-520), neladalkib (NVL-655), and NVL-330. Its products include Anoro Ellipta, Apretude, Arexvy, Bexsero, Blenrep, Blujepa, Boostrix, Cervarix, Dovato, Efimosfermin, among others.

Webull offers GSK plc (ADR) stock information, including NYSE: GSK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GSK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GSK stock methods without spending real money on the virtual paper trading platform.